Pfizer (PFE) Misses Q3 EPS by 9c; Reaffirms FY Outlook
Tweet
Share
E-mail
Get Alerts PFE Hot Sheet
Price: $28.95 +1.40%
Revenue Growth %: -4.4%
Financial Fact:
Discontinued operations--net of tax (in dollars per share): 0
Today's EPS Names:
RCBC, GASS, YSG, More
Revenue Growth %: -4.4%
Financial Fact:
Discontinued operations--net of tax (in dollars per share): 0
Today's EPS Names:
RCBC, GASS, YSG, More
Join SI Premium – FREE
Pfizer (NYSE: PFE) reported Q3 EPS of ($0.17), $0.09 worse than the analyst estimate of ($0.08). Revenue for the quarter came in at $13.2 billion versus the consensus estimate of $13.33 billion.
GUIDANCE:
Pfizer sees FY2023 EPS of $1.45-$1.65, versus the consensus of $1.50. Pfizer sees FY2023 revenue of $58-61 billion, versus the consensus of $55.37 billion.
For earnings history and earnings-related data on Pfizer (PFE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Palo Alto Networks (PANW) Tops Q4 EPS by 4c, Offers Guidance
- Barrick Mining said to delay IPO of American gold business to 2027
- Science Applications Int'l (SAIC) Tops Q2 EPS by 70c
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Earnings, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
